Devang Kalyanbhai Shah
About Devang Kalyanbhai Shah
Data last updated:
Devang Kalyanbhai Shah is a Director at Neoplus Criticare Private Limited (since 2003). The company operates in Healthcare. Neoplus Criticare Private Limited reported revenue of ₹2.15 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neoplus Criticare Private Limited U85100MH2003PTC140952 | Director | 18 Jun 2003 | 2003 | ₹2.15 Cr (FY 2024) | Active |
Board colleagues of Devang Kalyanbhai Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Charu Suraiya | 00735144 | Neoplus Criticare Private Limited | Director |
| Kamlesh Kumar Shrivastava | 00726778 | Neoplus Criticare Private Limited | Director |
| Mukund Chandulal Patel | 00735080 | Neoplus Criticare Private Limited | Director |
| Prashant Ramesh Gandhi | 00735155 | Neoplus Criticare Private Limited | Director |
| Sanjay Bhagwant Prabhu | 00752900 | Neoplus Criticare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devang Kalyanbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devang Kalyanbhai Shah
Devang Kalyanbhai Shah currently holds 1 directorship: Neoplus Criticare Private Limited (Director, since 18 Jun 2003, revenue ₹2.15 Cr (FY 2024)).
Devang Kalyanbhai Shah was first appointed on 18 Jun 2003 as Director at Neoplus Criticare Private Limited.
The current boards of Devang Kalyanbhai Shah's companies include Charu Suraiya (Neoplus Criticare Private Limited), Kamlesh Kumar Shrivastava (Neoplus Criticare Private Limited), Mukund Chandulal Patel (Neoplus Criticare Private Limited), Prashant Ramesh Gandhi (Neoplus Criticare Private Limited), Sanjay Bhagwant Prabhu (Neoplus Criticare Private Limited).